Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs
- PMID: 32742469
- PMCID: PMC7378935
- DOI: 10.7150/jca.46200
Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs
Abstract
In recent years, metabolic syndrome (Mets) has been a hot topic among medical scientists. Mets has an intimate relationship with the incidence and development of various cancers. As a contributory factor of Mets, hyperuricemia actually plays an inseparable role in the formation of various metabolic disorders. Although uric acid is classically considered an antioxidant with beneficial effects, mounting evidence indicates that a high serum uric acid (SUA) level may serve as a pro-oxidant to generate inflammatory reactions and oxidative stress. In this review, we describe the unrecognized role of hyperuricemia in cancer development and summarize major mechanisms linking uric acid to carcinogenesis. Furthermore, we also discuss the potential mechanism of liver metastasis of cancer and list some types of uric acid-lowering agents, which may exert anticancer effects.
Keywords: cancer risk; hyperuricemia; liver metastasis; metabolic syndrome; uric acid-lowering agents.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort.Atherosclerosis. 2015 Jul;241(1):271-7. doi: 10.1016/j.atherosclerosis.2015.04.797. Epub 2015 Apr 25. Atherosclerosis. 2015. PMID: 25957887
-
Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area.J Atheroscler Thromb. 2014;21(4):355-65. doi: 10.5551/jat.20529. Epub 2014 Jan 7. J Atheroscler Thromb. 2014. PMID: 24401703
-
The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome.Diabetes Metab J. 2019 Aug;43(4):504-520. doi: 10.4093/dmj.2018.0079. Epub 2019 Feb 21. Diabetes Metab J. 2019. PMID: 30877704 Free PMC article.
-
Uric acid lowering therapy in cardiovascular diseases.Int J Cardiol. 2016 Jun 15;213:20-2. doi: 10.1016/j.ijcard.2015.08.088. Epub 2015 Aug 12. Int J Cardiol. 2016. PMID: 26386814 Review.
-
Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?Curr Vasc Pharmacol. 2018;16(3):269-275. doi: 10.2174/1570161115666170621082237. Curr Vasc Pharmacol. 2018. PMID: 28676018 Review.
Cited by
-
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?Int J Mol Sci. 2022 Oct 5;23(19):11835. doi: 10.3390/ijms231911835. Int J Mol Sci. 2022. PMID: 36233136 Free PMC article. Review.
-
Potential antioxidative and anti-hyperuricemic components in Rodgersia podophylla A. Gray revealed by bio-affinity ultrafiltration with SOD and XOD.Front Pharmacol. 2023 Nov 8;14:1298049. doi: 10.3389/fphar.2023.1298049. eCollection 2023. Front Pharmacol. 2023. PMID: 38027025 Free PMC article.
-
Antimicrobial Properties of Colostrum and Milk.Antibiotics (Basel). 2024 Mar 11;13(3):251. doi: 10.3390/antibiotics13030251. Antibiotics (Basel). 2024. PMID: 38534686 Free PMC article. Review.
-
Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany.Breast Cancer Res Treat. 2023 Jun;199(3):545-552. doi: 10.1007/s10549-023-06944-w. Epub 2023 Apr 18. Breast Cancer Res Treat. 2023. PMID: 37071268 Free PMC article.
-
Association between serum uric acid and colorectal cancer risk in European population: a two-sample Mendelian randomization study.Front Oncol. 2024 Jul 1;14:1394320. doi: 10.3389/fonc.2024.1394320. eCollection 2024. Front Oncol. 2024. PMID: 39011473 Free PMC article.
References
-
- Yadav D, Lee ES, Kim HM, Choi E, Lee EY, Lim JS. et al. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis. 2015;241:271–7. - PubMed
-
- Park SK, Oh CM, Kim MH, Ha E, Choi YS, Ryoo JH. Metabolic syndrome, metabolic components, and their relation to the risk of pancreatic cancer. Cancer. 2020. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials